Dr. Ronald Roth's Research Library on Cellular Nutrition and Health Disorders
Herceptin is a drug used to treat HER2 breast cancer, found in about 20-25% of cases. Unfortunately, it has a staggering list of potential side effects. Everolimus is another, more recent HR breast cancer drug addition. Being an mTOR inhibitor, it counters the resistance of other drugs to hormonal therapy... Full Text